Natera, Inc. (NTRA)
NGS · Common · CUSIP 632307104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NTRA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
632307104
Market Cap
Mid Cap
IPO
7/1/2015 · $18.00/share
Business: Natera, Inc. is a diagnostics company. The Company has molecular and bioinformatics technology that it deploys to change genetic diseases across the world. Its molecular assays measure various regions across the genome from samples as small as a single cell. Its statistical algorithms combine these measurements with the available data to detect a range of serious conditions. It is engaged in developing products for various oncology applications. In addition to its direct sales force in the United States, the Company has a global network of over 70 laboratory and distribution partners. It has introduced a cloud-based distribution model. It also has launched seven molecular diagnostic tests.

Company Contact

CEO
Steve Chapman
CFO
Mike Brophy
Headquarters
13011 McCallen Pass, Building A Suite 100, Austin, TX
Phone
650-249-9090
Investor Relations
Herm Rosenman · 650-249-9090 · hrosenman@natera.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »